Evaluation of MHB3TM on Cartilage Loss / Knee Instability
In a chondro-protection study the effect of Baxyl®'s MHB3TM formulation was dramatic, preventing the progression of osteoarthritis into articular cartilage and preventing the formation of osteophytes (bone spurs) as well.
Evaluation of MHB3TM on the Development of Osteopenia
In a recent bone loss study the effects of oral MHB3TM (modified hyaluronan) supplementation on bone loss were investigated and found that MHB3TM significantly reduces the development of osteopenia associated with estrogen depletion.
Effects of MHB3TM on Cartilage Loss / Monoarthritis
In a disease modification study the benefits of Baxyl's MHB3TM were evaluated against existing osteoarthritis where it proved to have disease modifying benefits.
Evaluation of MHB3TM among Patients with Chronic Joint Symptoms
In a Chronic Joint Symptoms study the effect of Baxyl's MHB3TM formulation relieves joint pain and inflammation contributing to an improved range of motion and an increase in daily activity among the majority of subjects.